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Summary
Adult inguinal hernia development is a eommon general surgical problem with 85,000 
inguinal hernia repairs being performed annually in the United Kingdom. An 
understanding o f the aetiology is important as it may help improve operative repair or 
identify modifiable factors that could prevent the disease. The current understanding 
of adult inguinal hernia aetiology is complex and multi-factorial. The inguinal canal is 
a dynamic structure and paralysis of the deep inguinal ring or variations in parameters 
of the canal can predispose to hernia development. The presence of a patent processus 
vaginalis can also result in hernia development but can not alone explain the 
aetiology. There is a genetic component with a number of hereditary connective tissue 
and metabolic storage diseases being associated with inguinal hernia development.
The extra-cellular matrix is a complex alloy of protein families that provides a 
structural framework for tissues. It is a dynamic environment whose composition and 
activity varies between tissues. Control of this environment involves both paracrine 
and autocrine regulation by a wide spectrum of growth factors, hormones and 
enzymes. The mechanical properties of tendon and interstisital tissue extra-eel lular 
matrix is defined by the proportion o f type I : type III collagen within it. Adult 
inguinal hernia patients have been found to have reduced ratios of type I : type III 
collagen caused by elevated expression and production of type III collagen, occurring 
in both direct and indirect hernias. Levels of matrix metalloproteinases, the 
degredative enzymes of the matrix, have been found to be variable but may have an 
influence in younger inguinal hernia patients.
The growth hormone axis in adults influences body composition including protein, 
fat, carbohydrate and bone metabolism. It works directly by the effects o f growth 
hormone and indirectly via the mediator insulin-like growth factor-1. The axis activity 
declines with age and is associated with many of the changes in body habitus 
associated with ageing. The peak decline in this activity coincides with the peak 
incidence of adult male inguinal hernias. A variety of studies in the fields of 
dermatological, vascular and orthopaedic research have demonstrated that growth 
hormone, insulin-like growth factor-1 and age can modulate both collagen 
metabolism and MMP activity. Alterations in the ratio of type I : type III collagen
have also been noted. These observations are both time and tissue dependant. This 
study hypothesized that the growth hormone axis, in particular its age-related decline, 
could have a role in the aetiology of adult inguinal hernia development. Gonadal axis 
function also declines with age and this was assessed also.
47 adult male patients were recruited from 100 consecutive patients referred to the 
Southern General Hospital with inguinal hernias between 2003 and 2005. These were 
compared to 47 age-matched controls recruited from 850 patients reviewed with 
benign pathology in the general, orthopaedic and day-case clinics over a similar time 
period. Patients were excluded if they had any history of endocrine pathology, 
aneurysmal vascular disease, diabetes, liver or renal pathology or malignancy to 
exclude factors known to influence growth hormone axis activity. In addition, the 
control patients were examined by two independent clinical practitioners to exclude 
occult groin hernia and were also excluded if they had a history of ventral abdominal 
wall hernias. All other medical history, including smoking history, was noted and 
height / weight measurements were taken for calculation of body mass index. A single 
serum blood sample was taken for the analysis of IGF-1 (as a surrogate marker of 
GH/IGF-1 axis activity), testosterone and sex hormone binding globulin. The free 
androgen index was calculated from these results in order to exclude gonadal axis 
activity as a confounding factor.
Both groups were similar in baseline characteristics except for mean BMI ( mean 
BMI hernia 25.1 vs control 26.6; p=0.035). IGF-1 negatively correlated with age in 
both groups. There was a negative correlation with testosterone and age also. Free 
androgen index displayed a significant negative correlation with age which was 
maintained when controlling for BMI and IGF-1. There was a no significant 
difference between the mean IGF-1 concentrations of the hernia cohort compared to 
controls. The hernia cohort had significantly higher gonadal axis activity but this was 
within normal limits.
These results confirmed the recognized age-related declines in the growth hormone 
and male gonadal axis within this cohort. It did not show a significant difference 
between IGF-1 levels in the hernia and control groups. The noted elevated 
testosterone and free androgen binding index levels in the hernia cohort was
unexpected but certainly excluded reduced gonadal axis activity as an aetiological 
factor. This was the first study to investigate a possible relationship between adult 
inguinal hernia development and the growth hormone and gonadal axes. It suggests 
that the recognized hormonal changes associated with adult male ageing are not 
aetiological factors in adult male inguinal hernia development. Further research in this 
area is warranted to confirm these findings.
Section One: Review of Relevant Literature
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Chapter One 
The Aetiology of Adult Inguinal Hernia Development
1.1 - Introduction
Inguinal hernias are one of the most common general surgical conditions. They are 
10 times more common in males than females. The lifetime risk of developing an 
inguinal hernia for a normal adult male is approximately 5%, with a peak incidence 
in the fifth and sixth decades [1]. 85 0000 inguinal hernia repairs are performed per 
year in the National Health Service, with a peak rate of 75 per 10 0000 population 
in the 55 -  85-year age group[2]. Inguinal hernias can be associated with significant 
morbidity and mortality, especially in the elderly population[3], and their operative 
repair is not without risk[4]. An understanding of the aetiology of adult inguinal 
hernia is important as not only might it assist with improving operative repair but 
identification and modification of risk factors could also help prevent development 
of the disease.
In the 19^ '^  century, the cause of inguinal hernia was thought to be simply 
mechanical, due to increased intra-abdominal pressure. Cooper identified 
‘causative’ factors such as cough, obesity and constipation[5]. Over the last 100 
years, our understanding o f inguinal hernia development has expanded dramatically 
and the genetic, anatomical, physiological and biochemical factors that have been 
implicated in the aetiology of inguinal hernia will now be discussed.
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1,2 “ Anatomy and Physiology of the Inguinal Canal
The inguinal canal is a 4-6cm long oblique passageway through the anterior 
abdominal wall extending from the internal ‘deep’ ring to the external ‘superficial’ 
ring. The anterior wall is formed by the fibres of external oblique aponeurosis, 
reinforced by internal oblique fibres in its lateral third. The floor consists of the rolled 
edge of external oblique forming the inguinal ligament. The roof is made up of the 
arching fibres of internal oblique and transversus abdominus which arch from a 
position in front o f the cord laterally, where they re-inforce the anterior wall, to 
behind the cord medially, where their fibres condense to form the conjoint tendon.
This structure reinforces the medial aspect o f the posterior wall which is also formed 
from the transversalis fascia. In this way the deep and superficial rings, as potential 
weak points, are reinforced.
The myopectineal orifice of Fruchaud [6] has been well described and encompasses 
the region where all groin hernias occur (FigJ). It comprises the arching fibres of 
tranversus abdominis, internal and external oblique muscles superiorly, the ilium 
and pectineal ligament inferiorly, the rectus muscle medially and the ileopsoas 
muscle laterally. The inguinal ligament divides the area in two, allowing passage of 
the spermatic cord above and the femoral vessels below. Direct inguinal herniation 
occurs through the area called Hesselbach’s triangle, bound by the deep inferior 
epigastric vessels laterally, rectus muscle medially and iliopubic tract posteriorly.
The floor of the triangle consists of the weakened transversalis fascia. By definition, 
indirect inguinal herniation occurs lateral to the deep inferior epigastric vessels 
through the deep ring.
It is important to note that the deep ring is not a fixed opening but moves supero- 
laterally under the fibres of internal oblique and transversalis muscles on straining 
therefore increasing the obliquity of the opening at the deep ring [7,8]. This supero- j
lateral ring movement can be seen during local anaesthetic repair and has been 
described at laparoscopy [9], In addition, the conjoint tendon approximates to the 
inguinal ligament to ‘close o ff  Hesserf s Triangle; a triangle with the deep ring at its 
apex, rectus muscle at its base and conjoint tendon & inguinal ligament forming its 
sides (Fig. 2). The canal thus has dynamic mechanical protective factors
12
Ileo p so a s m u sc le
Inguinal ligam ent
Fem oral v e s s e l s
Sp erm atic  cord
M yopectineal orifice
Figure 1. Schematic representation of the myopectineal orifice of fruchaud.
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Ileo p so a s m u scle
Inguinal ligam ent
Fem oral v e s s e ls
Sp erm atic  cord
M yopectineal orifice Hessert’s Triangle
Figure 2. Schematic representation of Hessert s triangle
The blue triangle bound by the conjoint tendon, inguinal ligament and rectus muscle 
is Hessert’s triangle. The arrow indicates the direction of movement of the conjoint 
tendon towards the inguinal ligament on straining thereby re-inforcing the underlying 
weak transversalis fascia.
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against herniation. A recent study found the size of Hessert’s triangle in patients 
undergoing hernia repair was significantly larger than compared with fresh 
cadavers. This difference was due to a higher intersection of internal oblique with 
the rectus muscle. It was suggested this may make occlusion of the triangle on 
straining incomplete and predispose to hernia formation [10].
It would certainly appear therefore that normal function of the lateral abdominal 
muscles and transversalis fascia are important factors in protecting the inguinal 
canal. An increased incidence of right inguinal hernia has been shown following 
appendicectomy [11,12] and this has been attributed to damage to the segmental 
nerves supplying the internal oblique and transversalis muscles paralysing the 
above protective mechanisms. This was demonstrated by Tobin and colleagues who 
described a case of right inguinal hernia developing six months following 
appendicectomy in whom laparoscopy showed normal deep ring movement on the 
left side but paralysis of the deep ring on the right [9].
Hahn-Pedersen and co-workers have used CT scanning to visualise the dilatation of 
the femoral vein during periods of increased abdominal pressure [13]. They claim 
that this dilatation acts to close the femoral canal and so protect against herniation 
into the space. Similar techniques were then used to investigate patients with 
inguinal hernias [14]. In the normal inguinal canal they have shown no change in 
the diameter o f the pampiniform plexus veins lateral to the conjoint tendon. 
Medially, however, they have demonstrated distention of these veins. The same 
changes were demonstrated in patients who had direct inguinal hernias, but in 
patients with indirect hernias there was no demonstrable dilatation of the veins. The 
authors suggested that there may be a “vascular on-demand closing mechanism” 
which works along with the other protective mechanisms to prevent inguinal 
herniation. They speculated that a competent valve in the spermatic vein at the level 
of the deep ring would prevent filling and therefore predispose to inguinal hernia 
formation. It was acknowledged, however, that the phenomenon may simply 
represent a passive occupation of the gap between the conjoint tendon and the 
external oblique aponeurosis during periods of raised intra-abdominal pressure.
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1.3 - Saccular Theory
In 1906 Hamilton Russell, an Australian paediatric surgeon, published the Saccular 
Theory of Hernia [15]. This theory “rejects the view that hernia can ever be 
‘acquired’ in the pathological sense” and maintains that “the presence of a 
congenital peritoneal sac is a necessary antecedent condition in every case of 
ordinary abdominal hernia.” In the case o f indirect inguinal herniation the 
congenital sac is formed by the failure of closure of the processus vaginalis. These 
congenital sacs have been found to contain smooth muscle within their walls which 
is thought to be a reason for failure of obliteration of the processus [16]. Russell 
states, “When the peritoneal tube is obliterated fairly up to the level of the opening 
in the transversalis fascia the occurrence of inguinal hernia in the future will be 
impossible.” In this paper the presence of the ‘sphincter’ mechanism produced by 
the conjoint tendon apposing to the inguinal ligament is described, but Russell felt 
that the presence of a peritoneal sac in the canal was enough to render the muscular 
apparatus ineffective and allow herniation to occur,
Hammond, in 1923, criticised the Saccular Theory because it could not account for 
the delay in hernia formation until adult life [17]. Unlike Russell he felt that the 
sphincteric action of the conjoint tendon normally was able to protect the deep ring 
even with the presence of a patent processus vaginalis. Inguinal herniation was 
thought to occur when the muscular mechanism was overcome by severe or prolonged 
strain or there was a sudden inco-ordination of the muscular activity, in essence 
increased abdominal pressure. It is now known that up to 10% of male patients treated 
by continuous ambulatory peritoneal dialysis (CAPD) develop an inguinal hernia 
[18]. These hernias occur within a few months of commencing CAPD and all are of 
the indirect type [19]. A two litre intraperitoneal dialysate volume equates to a 
pressure of 30-40cm of water at the inguinal level when the patient is in the upright 
position [20]. It is thought that this pressure causes distention of a patent processus 
vaginalis leading to development o f an indirect inguinal hernia [18,20]. Grosfeld and 
Cooney have suggested that the same mechanism is responsible for an increased 
incidence of indirect inguinal hernias in infants after ventriculo-peritoneal shunt for 
hydrocephalus [21].
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Harrison observed that, while the muscles of the abdominal wall seemed to be 
normal in structure and development, the transversalis fascia was weak. He 
therefore concluded that the cause of inguinal herniation was a failure of the 
transversalis fascia to withstand the intra-abdominal pressure to which it was 
subjected [22]. This view was supported by Keith who argued that sac formation 
did not cease at birth but in fact could occur at any stage in life under suitable 
circumstances [23]. Keith stated that, “All femoral hernias are produced in this
m anner and so are all d irect inguinal hernias.........for none o f these is there a
vestige of evidence that the sac was formed before birth and by developmental 
means.” Like Harrison, Keith thought that the increased incidence of inguinal 
hernias in the middle aged and elderly was due to a pathological change occurring 
in the abdominal wall.
Further evidence against the theory of a purely congenital aetiology for groin 
herniation is found in the observation that 15-20% of healthy adult males [7,24] 
have a patent or partially patent processus vaginalis throughout life without ever 
developing an inguinal hernia. An indirect inguinal hernia has also been 
documented in a man proven not to have a patent processus by herniography prior 
to development o f the hernia [25]. Similarly, Gullmo observed that 5% of young 
women who had incidental herniography after hysterosalpingography had an open 
processus vaginalis without clinical evidence o f a hernia [26]. In most mammals the 
testes pass through the abdominal wall to reach the scrotum, and only in man and 
the gorilla is the processus vaginalis normally closed afterwards. Therefore, in most 
other mammals a patent processus vaginalis is always present and yet inguinal 
herniation is much less common at every stage of life [23].
Man’s predisposition to inguinal herniation has been attributed to the attainment of 
an upright posture, with the observation that quadrupeds have similar deficiencies 
in the inguinal region as erect mammals without the associated herniation [27]. 
However, Keith argued that it was the modifications of the pelvis for bipedal 
locomotion that weakened the inguinal region rather than simply having an upright 
posture [23]. Similarly, Parry argued that if upright posture alone was responsible 
femoral herniation should be more common in view of the dependant position of 
the femoral canal [28]. He observed that an action which quadrupeds cannot do, but
17
which man does frequently and forcibly, is rotation of the trunk. Parry associated 
this factor with the high incidence of inguinal hernia in man.
18
1.4 - Hereditary Factors
Inguinal hernia is a common feature in many hereditary diseases of connective 
tissue. In a review of 50 consecutive cases of Marfan’s syndrome Pyeritz and 
McKusick described a 22% incidence of inguinal hernia [29]. In this paper it was 
also stated that inguinal hernias associated with this condition tended to recur after 
surgical repair. Types I and IX of Ehlers-Danlos Syndrome (EDS) are also 
associated with an increased incidence of hernias [30], While the molecular defect 
in type I EDS is not known, a defect in copper metabolism is present in most 
patients with type IX EDS[31]. Copper is an essential co-factor for lysyi oxidase 
(see section 1.5). In view of the association between abdominal aortic aneurysm 
(AAA) and inguinal hernias(see section 1,6), it is interesting to note that AAA has 
also been associated with similar abnormalities in copper metabolism [32,33]. 
Reduced plasma and hernial sac copper levels have recently been found in a gioup 
o f direct inguinal hernia patients[34].
Another group of hereditary disorders associated with an increased incidence of 
inguinal hernia are the mucopolysaccharidoses (including Hurler’s Syndrome and 
Hunter’s syndrome) [35]. In these conditions storage related abnormalities in 
connective tissue produce a laxity which is manifest by inguinal and umbilical 
hernias. A high incidence of adult hernia formation amongst the Inuit o f Greenland 
has been linked with a high incidence of the HLA-B27 allele [36], which is also 
associated with a number of connective tissue diseases. Inguinal hernia has also 
been shown to occur more frequently in children with congenital dislocation of the 
hip [37].
Heredity has been included amongst the factors thought to predispose to paediatric 
inguinal hernia for many years [38-41]. Marshall and co-workers used the twin- 
study method to demonstrate a significantly higher concordance for hernia 
formation in monozygotic compared with dizygotic twins [42]. The nature of 
genetic transmission, however, has not yet been clearly defined. Hypotheses 
proposed include autosomal dominant with incomplete penetrance [39,41], 
autosomal dominant with sex influence^* ,^ X-1 inked dominant [38], and polygenic
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inheritance [43]. From a study of 707 index cases of congenital inguinal hernia 
Czeizel and Gardonyi produced data supporting a multifactorial threshold model 
involving dominance variance [44]. However, Gong and co-workers have recently 
reported on an analysis of 280 families with congenital indirect inguinal hernia in 
the Shandong province of China which does not support this model [45]. They 
found frequent vertical transmission and a high segregation ratio which suggest that 
an autosomal dominant pattern with incomplete penetrance and sex influence is the 
most likely mode of inheritance. Evidence supporting preferential paternal 
transmission of the disease gene was also found.
20
1.5 -  Collagen and the Extra cellular Matrix
The extracellular matrix (ECM) is a complex alloy of protein families that provides 
a structural framework for all types of tissue. ECM is composed of a variety of 
collagens, glycoproteins, proteoglycans and elastin and its structure varies 
depending on the site to provide specific micro-environments for cellular functions 
and interactions [46]. The collagens are the major components of ECM maintaining 
structural integrity. Far from being a static environment, the ECM is dynamic and 
undergoes continuous remodelling. Protein synthesis is balanced by a specific 
enzyme family called matrix metalloproteinases (MMP) that control protein 
degradation [47]. The action of MMPs can release biologically active molecules 
that influence the cellular micro-environment [48]. Furthermore, the ECM 
environment can be influenced by a variety of cytokines and growth factors that 
provide an additional layer of control. An understanding of both collagen and ECM 
biology is essential to both understanding and developing current knowledge on 
disordered ECM function in adult inguinal hernia development.
Collagen Metabolism
Collagen is defined as a structural protein of the extracellular matrix which contains 
one or more domains with the conformation of a collagen triple helix [49]. There 
are currently 26 collagen types described (table 1) which can be grouped depending 
on their molecular structure and supra-molecular organization [46,50]. It is the 
fibril-forming collagens that provide tensile stiffness and strength to tendons and 
interstitial tissues and are therefore of interest when discussing hernias. It is these 
collagens that will be focused upon in this section.
Regardless of type, all collagens contain at least one characteristic triple helix 
domain. This consists of three polypeptide chains (a-chains) each with a repeating - 
Gly-X-Y- amino acid sequence with the X and Y positions most often being 
occupied by proline, hydroxy-proline and hydroxy-lysine residues [51]. Each of 
these chains forms left-handed helixes which coil around a central axis to form a
21
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right-handed triple helix. The glycine residue occupies every third position as it is 
the only amino acid small enough to fit in the centre of this helix. This also means 
that the other residues are always positioned on the outside of the structure to allow 
intra- and inter- molecular interactions to occur. The collagen domain can be a 
homo-trimer or hetero-trimer depending on whether the individual a-chain 
sequences are identical or not.
Initial transcription and translation of these a-chains is highly complex but 
regardless of this, they all undergo important post-translational modifications that 
confer immense strength to the collagen triple helix:
1. Pro line Hvdroxvlation.
Prolyl-4-hydroxylase converts proline residues to 4-hydroxyproline [52]. This is 
essential for intra-molecular hydrogen bond formation within the collagen 
molecule. This process is highly oxygen dependent. Studies of the melting 
temperature of unhydroxylated collagen (the temperature at which the protein 
molecule de-natures) show that it is lower indicating the triple helix is markedly 
less stable [5 3]. The hydroxylation of proline residues is therefore important for the 
molecular stability and strength of collagen.
Proly 1-3-hydroxylase converts proline residues to 3-hydroxyproline but the 
functional significance of this is unclear[46].
2. Lysine Hydroxylation.
Lysine hydroxylation is catalysed by lysyl hydroxylase [54]. This allows 
subsequent formation of intermolecular cross-links by joining two hydroxylysine 
residues and one lysine residue through the action of lysyl oxidase. [51]. This helps 
proyide stability to the matrix of extra-cellular collagen molecules. Hydroxylation 
of lysine residues also allows the residues to be further modified by other enzyme 
systems, such as hydroxylysyl galactosyltransferase, to allow addition of 
carbohydrates [55].
The fibrillar collagen molecules contain a triple helix 300nm in length which have 
non-helical domains, called C- and N- propeptides, at either end. Following 
excretion into the extra-cellular environment, these propeptides are cleaved by 
specific C- and N- protelnases respectively. This triggers the spontaneous assembly 
of the collagen molecules into highly ordered and orientated fibrils [50]. These 
fibrils are characterised by a striated appearance on electron microscopy that 
represents a staggered alignment of collagen molecules within the fibril[51]. It is at 
this point that the lysyl oxidase family of enzymes creates strong inter-molecular 
covalent bonds between aligned molecules[56].
It is important to note that, although each type of collagen can form fibrils on their 
own, they often bind with other collagen types like a molecular alloy [49]. It is this 
interaction that bestows specific physical and biological characteristics to different 
tissue sites. Type I collagen is the predominant collagen within connective tissue, 
bestows mechanical strength to those tissues and represents 90% of all 
collagen[46]. It is the predominant collagen within fascia, tendon and skin. On its 
own it would form thick, strong fibrils as seen by the number of covalent bonds 
between adjacent molecules. Type III collagen, in contrast, would form thinner 
fibrils with fewer bonds[5 7]. It provides a degree of elasticity and compliance to the 
tissues it is within. In vivo. Type I and Type III collagens form collagen fibrils 
together [5 8]. The ratio of the ‘strong’ Type I to the ‘weak’ Type III molecules 
within the fibrils therefore determine the strength and physical characteristics of the 
overall tissue. It is thought that a higher relative content of Type III collagen would 
create ‘weaker’ tissue by reducing the covalent bonding between molecules within 
the fibrils and thereby reducing their size and physical characteristics [59].
Matrix Metailoproteinases
The matrix metailoproteinases are a family of proteases that are integral to the 
regulation of the ECM. They can degrade any component of the ECM[60], release 
bio-active fragments including growth factors and inflammatory mediators from the 
ECM[48], stimulate cell migration through the ECM[47] and are increasingly 
implicated in a wide spectrum of human physiology. MMPs are zinc-dependent 
enzymes that have a distinctive domain structure including pro-peptide, catalytic
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and substrate domains. They are secreted as inactive zymogens due to a 
characteristic ‘cysteine switch’ in which an unpaired cysteine in the pro-peptide 
interacts with the zinc ion in the catalytic domain to exclude an essential water 
molecule[61]. The proteolytic removal o f this pro-peptide activates the enzyme.
The exact mechanism varies with each MMP and is one of the key features in their 
regulation. Expression profiles very between normal tissues with elevated activity 
seen in a variety of physiological and pathological states such as wound healing, 
arthritis or cancer[62-64]. Activity is influenced at translation, transcription and 
activation by a wide range of growth factors and cytokines as well as cell-cell and 
ECM-cell interactions[65]. A family of 4 inhibitors, tissue inhibitors of MMPs 
(TIMPs), can both inhibit and potentiate MMP action and provide a further layer of 
control [66].
28 MMPs have been identified currently and are described numerically based on the 
order they were discovered[47]. These can be categorised on the basis of their 
substrate specificity into collagenases, gelatinases, stromelysins and membrane-type 
MMPs (MT-MMP) [see table 2], It is the collagenases that are of importance when 
considering the fibrillar collagens. Fibrillar collagens consist almost entirely of the 
collagen triple helix domain and are extremely resilient to enzymatic degradation. 
Only the MMP family can degrade the collagen triple helix within the different 
collagens and the collagenases have most specificity for the fibrillar collagens[65]. 
Therefore, MMP-1, MMP-8 and MMP-13 activities determine the rate of fibrillar 
collagen breakdown and could theoretically influence the tensile strength of tissues 
high in type-I and type-III collagens.
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Category Enzyme Name
(where applicable)
MMP number
Collagenases Collagenase-1 MMP-1
Collagenase-2 MMP-8
Collagenase-3 MMP-13
Collagenase-4 MMP-18
Gelatinases Gelatinase-A MMP-2/MMP-5
Gelatinase-B MMP-9
Stromelysins Stromelysin-1 MMP-3 / MMP-6
Stromelysin-2 MMP-10
Sromelysin-3 MMP-11
Membrane-type MMPs 
(MTMMPs)
MTMMP-1 MMP-14
MTMMP-2 MMP-15
MTMMP-3 MMP-16
MTMMP-4 MMP-17
MTMMP-5 MMP-24
MTMMP-6 MMP-25
Matrilysins Matrilysin-l MMP-7
Matrily sin-2 MMP-26
Others Metalloeiastase MMP-12
Enamelysin MMP-20
Epilysin MMP-28
No name assigned MMP-19, MMP-21 
MMP-22 / 27, MMP-23
Table 2. Classification of matrix metailoproteinases
(Source: MEROPS:the proteasc databasc[http//merops.saiiger.ac.ukj)
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1.6 - Evidence for disordered collagen metabolism
Although Harrison in 1922 was the first to suggest that there may be a pathological 
change in the abdominal wall causing hernia formation, it was not until the 1970’s 
that the concept of defective connective tissue, specifically collagen deficiency, was 
introduced. Read noted the rectus sheath appeared thin in patients undergoing 
hernia repair, especially in those with direct defects [67]. Wagh and Read then 
demonstrated reduced levels of hydroxyproline in sheath biopsies of both direct and 
indirect hernia patients compared with controls, with the biggest reduction in direct 
herniation. They proposed the thinning of the rectus sheath was due to a deficiency 
in collagen and hypothesized this was likely to be a failure of hydroxylation of 
proline or lysine, or incomplete formation of the collagen molecules, rather than a 
defect of cross-linking. Reduced collagen synthesis by fibroblasts was subsequently 
demonstrated in hernia patients [68,69]. Connor and Peacock demonstrated in rats 
that a combination of a structural defect (enlargement of the deep ring) and a 
metabolic defect (chemically induced impaired cross linking of collagen) was 
required to reliably induce direct and indirect inguinal hernias [70]. These early 
studies suggested that a degree of ‘collagen deficiency’ was required for all types of 
inguinal herniation and that, from an aetiological perspective, the differentiation of 
direct and indirect defects was not relevant.
Connor and Peacock suggested that the abnormalities of collagen metabolism may 
be localised to the inguinal region. In contrast, Read’s group suggested inguinal 
hernia was a local manifestation of a systemic change in collagen metabolism. Read 
had noted developments in the understanding of pulmonary emphysema, previously 
thought to be due to mechanical pressure effects. In 1963, Laurell and Erikson 
reported an association between low levels of a protease inhibitor alpha-1- 
antitrypsin (alA T) and an inherited form of pulmonary emphysema [71]. In 1965, 
Gross et al induced experimental emphysema in rats using a crude plant protease. 
From these papers developed the ‘ protease-anti-protease’ theory of pulmonary 
emphysema in which an imbalance of protease activity and protease inhibition in 
the lung parenchyma mediated alveolar destruction. a lA T  was found to be a 
specific inhibitor of neutrophil elastase (produced by polmorphonuclear
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leukocytes), which on its own also induced experimental emphysema [72]. 
Subsequently, compounds within cigarette smoke were shown to inactivate a l  AT 
and thus were implicated in an ‘acquired’ emphysema [73].
Read had noticed that many of his hernia patients were also smokers. In a paper 
titled “Metastatic Emphysema”, Cannon and Read demonstrated an increase in 
serum elastolytic activity and a decrease in serum alpha-1-antitrypsin activity in 
smokers with hernias when compared with non-smoking controls [74]. They 
claimed that an imbalance o f blood proteases and antiproteases resulting from 
cigarette smoking could damage connective tissue in the inguinal region as well as 
in the lung. Jorgensen et al, using implanted ePTFE in human volunteers as a model 
of wound healing, subsequently demonstrated reduced levels of hydroxyproline 
deposition in healing wounds of smokers [75]. They related this to hypoxia at a 
cellular level caused by smoking both from nicotine induced vasospasm and 
carboxyhaemoglobin formation from inhaled carbon monoxide interfering with the 
activity of prolyl-4-hydroxylase. However, a wide variability in hydroxyproline 
deposition was also noted amongst the non-smoking controls. Recently the same 
group have demonstrated that smoking is a risk factor for groin hernia recurrence 
[76].
Read’s group noted a similar imbalance in blood proteases and antiproteases in 
patients with abdominal aortic aneurysm (AAA), but not in those with aorto- 
occlusive disease[77]. They therefore hypothesised that there should be an 
increased incidence o f inguinal hernia in patients with AAA, in keeping with a 
‘systemic’disorder. In a retrospective study, Cannon and co-workers found that the 
frequency of inguinal hernia was higher in AAA patients (25.8%) compared with 
patients with Leriche syndrome (14.6%) [78]. Subsequent studies have shown an 
increased incidence of inguinal hernia in patients with AAA disease rather than 
aorto-occlusive disease, coronary atherosclerosis or peripheral vascular disease [79- 
81]. The prevalence of AAA has been shown to be 12.2% in male patients aged 
over 55 years having undergone hernia surgery compared with age-matched 
controls without such a history [82].
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With increasing evidence o f ‘weakened’ connective tissue associated with inguinal 
hernia development, Friedman et al looked at collagen synthesis in inguinal hernia 
patients by measuring pro-collagen secretion from cultured skin fibroblasts[83]. 
There was an increased expression o f Type III procollagen mRNA with 
concomitant increased production of Type III collagen resulting in a relative 
reduction in Type I : Type III collagen ratio compared to controls. There was no 
difference between direct and indirect hernia subgroups. They hypothesized the 
collagen ‘deficiency’ was therefore a qualitative rather than quantitative one.
Schumpelick et al revealed similar alterations in collagen ratios in skin and hernia 
sac samples. They also analyzed for MMP-1 and MMP-13 and found no difference 
between hernia patients and controls suggesting the collagen disorder was more 
likely of synthesis, rather than degradation[59,84]. Subsequently, using 
oligonucleide primers for the published gene sequences for Type I / Type III 
collagen and MMP-1 / MMP-13, the same team have demonstrated similar results 
for the transcription of the collagen and MMP genes with a relatively reduced Type 
I : Type III collagen ratio[85]. Similar collagen ratios were found with incisional 
hernias[86] and recurrent inguinal hernias[87] but the latter was associated with 
elevated levels of MMP-1 and MMP-13 compared to those seen in ‘normal’ scar 
tissue.
In another study, Bellon et al analyzed collagen ratios, proline & lysine 
hydroxylation, MMP-1 and MMP-2 expression in the transversalis fascia of hernia 
patients[88]. Again, there was no difference in collagen levels between indirect and 
direct hernia patients but elevated MMP-2 expression in young (20-40 years) 
patients with direct hernial defects was noted. Altered lysine hydroxylation was 
noted in the older (21-60 years) patients but the study was hampered by small 
numbers and lack of control group. The same team, however, subsequently found 
increased fibroblast MMP-2 expression in young direct hernia patients compared to 
indirect and control patients[89] with reduced MMP-2 levels in the older patients. 
As MMP-2 degrades non-fibrillar components of the ECM (including elastin) this 
raises the possibility that the hernial process may be different between young and 
old patients. Recently, elevated TIMP-2 levels have been found in transversalis
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fascia samples from direct inguinal hernia patients and could be a factor in the 
increased MMP-2 expression seen in the bellon studies[90].
Harrison commented on the fact that the peak incidence of inguinal hernias in adults 
occurs at a time of life when physical activity may be reduced as men come towards 
the end of their working life [22]. Similarly, lack of physical exercise has been 
associated with development of inguinal hernias [91]. Prolonged reduction in 
muscular activity has been shown to reduce the tensile strength of tendons. [92]. 
Karpakka and co-workers have further shown that muscle contractile activity and 
tension seem to be positive regulators o f prolyl 4-hydroxylase and 
galactosylhydroxylysine glucosyltransferase. [93]. These factors could also 
contribute to altered collagen synthesis at a local level.
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1.7 - Conclusions
Initially, inguinal hernia development was related to anatomical and mechanical 
factors with a raised intra-abdominal pressure and patent processus vaginalis 
overcoming the physiological protective mechanisms of the inguinal canal. Early 
observations of the qualitative deficiencies of tissue within the groin were not 
heeded. The association of inguinal hernia disease with a number of metabolic and 
connective tissue diseases, and experiments suggesting a systemic 
‘protease/antiprotease imbalance’ in patients with inguinal hernia, emphysema and 
aortic aneurysm, again focused concentration on the fascia of the canal and the 
extra-cellular matrix within it. Adult inguinal hernia patients have been found to 
have reduced ratios o f type I : type III collagen caused by elevated expression and 
production of type III collagen, occurring both in direct and indirect hernias. The 
role of MMPs in hernia development is not clear. The collagenases do not appear to 
be elevated in primary inguinal herniation but MMP-2 activity has been found in 
some hernia patients, with elevated MMP-1 and MMP-13 seen in recurrent hernia. 
MMP expression, however, is under tight control and ‘snapshot’ levels may not 
represent overall activity over a period of time. Also, both collagen synthesis and 
MMP expression / activation are influenced by a variety of cytokines and hormones 
systemically and at a local level. Further understanding of the physiology of the 
ECM environment is required to fully explain the reasons behind adult inguinal 
hernia development.
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Chapter Two 
The Adult Growth Hormone / IGF-1 Axis
2.1 -  Introduction
The somatotrophin axis comprises the hypothalamus, pituitary gland and numerous 
target tissues. Via the actions o f Growth Hormone (GH) and Insulin-like Growth 
Factor-1 (IGF-1), and under tight neiiro-hormonal control, the axis is an important 
determinant of body composition. During puberty, it is responsible for axial somatic 
growth. In adulthood, it continues to be an essential anabolic pathway for the 
control of body composition and is intimately involved with changes in body 
habitus associated with ageing [94]. A complex topic in its own right, this chapter 
will provide an overview o f the somatotrophin axis prior to focusing on the 
alterations of the axis associated with ageing and ultimately the potential influence 
the pathway has on collagen metabolism.
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2.2 -  The Somatotrophin Axis 
Growth Hormone
Growth hormone (GH) is a 191 amino acid protein produced by the anterior 
pituitary somatotropes. It does not have a specific target organ but exerts a variety 
of effects either directly or via the Insulin-like Growth Factor system (IGF-IJGF- 
2)[94]. GH is secreted in pulsatile bursts and is subject to diurnal variation, with 
peak secretion occurring nocturnally during deep phase III/IV sleep [95,96]. GH 
circulates bound to GH binding protein (GHBP) which is derived Irom the extra­
cellular domain of the GH receptor[97,98] and complexes around 90% of 
circulating GH[99].
The growth hormone receptor (GHr) is expressed by most cells of the body. GH has 
two binding sites for the GHr with its activation requiring formation o f a dimer 
between two receptors and one GH molecule [100]. This results in activation of 
Janus Kinase 2 (JAK2) which leads to phosphorylation of ‘Signal Transducers and 
Activators of Transcription’ or ST AT proteins [101]. These STAT proteins activate 
gene transcription and generation o f proteins such as IGF-1 [102]. GHr activation 
can also activate the Insulin Receptor Substrate (1RS) proteins [103] which are 
responsible for many of the direct metabolic effects of GH.
IGF-1
IGF-1 is the mediator for the indirect actions of GH. The majority of circulating 
IGF-1 is hepatocyte-derived [104] and correlates well with GH axis activity. 
However, animal models have demonstrated that normal gi'owth and development 
can occur in the absence o f hepatic IGF-1 production [105] and both animal and 
human studies have shown that local tissue concentrations of IGF-1 can differ 
significantly from serum concentrations [106,107]. Autocrine and paracrine 
production of IGF-1 is therefore just as important for its action. Not all production 
requires the influence o f GH and both the sex steroids and glucocorticoids can 
affect the production and activity of IGF-1 and its binding proteins [108,109].
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IGF-1 has a family of six IGF-binding proteins (IGFBP) to which it can bind [110]. 
These not only serve as carrier proteins, IGFBP-3 binding 70% of serum IGF-1, but 
also function to regulate the actions of IGF-1. Although poorly understood, this is 
not simply achieved by controlling the amount of free IGF-1 available for 
interaction at a local tissue level. Experimental studies have suggested there is a 
complex interplay between the IGFBPs and IGF-1. IGFBPs can influence cellular 
responsiveness to IGF-1 [111,112] as well as IGF-1 availability [107,110]. In 
return, IGF-1 can modulate IGFBP expression [109], Some of the effects of IGF-1 
require synergistic action with IGFBPs [113]. The IGFBPs can also act 
independently as growth factors, directly stimulating transcription and activation of 
genes [110].
IGF-1 mediates its effects via the IGF-1 receptor (IGF-lr) or the receptor for Insulin 
(to which it is structurally related) [114]. Activation of the IGF-lr results in a 
complex activation of multiple intra-cellular signalling pathways, including the 1RS 
proteins and the mitogen activated protein (MAP) kinase signalling pathway [115]. 
These eventually result in the stimulation of transcription and the various effects of 
IGF-1.
Neuro-hormonal control of Growth Hormone
GH synthesis and release is predominantly controlled by two opposing 
hypothalamic hormones -  Growth Hormone Releasing Hormone (GHRH) and 
Somatostatin (SN). GHRH promotes the synthesis and release of GH whereas SN 
inhibits it[94]. The majority o f GH release is determined by resting SN inhibitory 
tone with the interplay of this and GHRH determining the pulsatile nature of GH 
release[94]. In addition to hypothalamic control, a hormone called Ghrelin has been 
identified [116] that is produced predominantly by stomach endocrine cells and 
stimulates GH release in response to nutritional intake [117]. lGF-1 helps to 
regulate GH release both at the hypothalamic and pituitary levels via a negative- 
feedback loop [94] (fig.3).
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Figure 3. Schematic diagram of growth hormone / IGF-1 axis regulation.
GH denotes Growth Hormone; IGF-1, Insulin-like Growth Factor-I; GHRH, GH- 
Releasing Hormone.
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Hypothalamic control can be further modulated by endocrine factors (thyroxine, 
glucagon, sex steroid and adrenal hormones), metabolic factors (glucose, free fatty 
acids) and psychological status (stress, depression) [94]. Free fatty acids and 
glucose concentrations also influence GH release at the pituitary level. 
Additionally, adiposity, lean body mass, exercise and hepatic and renal pathology 
can also affect the activity of the somatotrophin axis [93,118,119].
Clinical Effects of the Axis in Adults
GH and IGF-1 have a variety of independent and linked effects on:
1. Nitrogen Balance
Both GH and IGF-1 stimulate protein synthesis with or without inhibition of 
proteolysis dependent on the patho-physiological state of the subject [120]. This 
results in an overall positive nitrogen balance.
2. Lipid Metabolism
GH directly influences adipocytes by increasing catecholamine receptor sensitivity 
and number and thereby stimulating lipolysis [121]. Induction o f hepatic LDL 
receptors results in an improved serum lipid profile [122]. GH differentially both 
inhibits and stimulates lipoprotein lipase activity in adipocyte and striated muscle 
respectively, resulting in an overall increase in serum Free Fatty Acids (FFA) 
[121,123].
The above actions promote increased lean body mass and reduction and 
redistribution of fat mass from central to peripheral areas.
3. Carbohvdrates (CHOI
GH can increase hepatic gluconeogenesis, decrease CHO breakdown and stimulate 
insulin resistance [124] but none of these are particularly clinically significant 
within normal physiology. IGF-1 has beneficial effects on CHO metabolism 
including increased insulin sensitivity [125], especially on striated muscle. It can 
also induce insulin-like effects by direct stimulation of the insulin receptor[l 15].
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4. Bone and Cartilage
Growth hormone stimulates the differentiation o f pre-chondrocytes and increase the 
sensitivity of chondrocytes to IGF-1 as well as stimulating production of IGF-1 
mRNA [126,127]. IGF-1 stimulates proteoglycan, glycosaminoglycan and collagen 
synthesis by chondrocytes [128] and has also been shown to increase IGF-1 mRNA 
expression by osteoblasts. The clinical significance of the GH / IGF-1 axis in 
healthy subjects is unclear but its’ importance is seen in growth hormone deficient 
patients with reduced bone mass and increased risk of fractures [129].
5. Immune System
The GH / IGF-1 axis has been shown to influence the immune system. IGF-1 acts 
as a differentiation factor encouraging B-cell maturation [130] and can stimulate 
immunoglobulin production [131]. GHr are expressed by immunological cells 
which can also produce GH [132] .The clinical significance of axis activity on 
immune function is not clear.
Growth hormone deficiency states have also suggested a role for GH / IGF-1 in 
neuro-psychiatric status and cardiac and renal function [94].
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2.3 -  The Somatopause
Following the growth spurt in puberty and early adulthood, the activity o f the 
GH/IGF-1 axis declines with age. It has been estimated that with each decade, GH 
synthesis declines by 14% and GH half-life by 6% [133]. This is associated with a 
gradual decline in serum IGF-1 levels from the third decade onwards [134] with peak 
decline during the fifth and sixth decades. This age-related decline in the 
somatotrophin axis has been termed the ‘somatopause’ and is now well recognized as 
one of the endocrinological hallmarks of ageing [135-137].
The somatopause has been associated with the changes in adult body habitus and 
function that occur with ageing. These are strikingly similar to those changes seen 
with adult growth-hormone deficiency syndromes (AGHD) [94] and include:
- Increased fat mass, esp. in the abdomino-visceral compartment [138-140]
- Reduced lean body mass [138-140]
- Reduced muscular strength and exercise capability [141]
- Reduced bone mineral density [129]
- Altered lipoprotein and carbohydrate metabolism [142,143]
- Impaired renal and cardiac function [94,144,145]
- Impaired psychiatric wellbeing [146,147]
As well as the GH /IGF-1 axis, gonadal sex steroid function also declines with age 
[135]. It is difficult to separate some of the effects of this decline from those 
associated with the GH/IGF-1 axis. Both hormonal axes can also influence each 
others’ activity and actions [136,148]. Although testosterone levels remain within 
low-normal levels with age [135], and the evidence for its effects on body habitus is 
less compelling [149], sex steroid status should be taken into account when 
considering the effects of the somatopause and human ageing.
Fat mass has been shown to be inversely proportional to GH and IGF-1 activity 
independent of age [150,151]. Body mass index (BMI) can result in false findings of 
growth hormone deficiency on provocative testing (although does not seem to alter
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IGF-1 findings) [152]. Animal studies have suggested adiposity may alter 
noradrenergic neuronal regulation of the hypothalamus, alter the expression of ghrelin 
receptors and modulate GHRH cells within the hypothalamus [153-155]. Thus, it is 
not clear whether the noted changes in adiposity with age are a cause or effect of 
concomitant declining GH/IGF-1 activity.
The mechanism underlying the somatopause has yet to be fully elucidated. Both 
human and animal studies have demonstrated a reduction in GHRH synthesis [156], 
reduced pituitaiy response to GHRH [157] and elevation of somatostatin tone [158] 
with age. Other studies have suggested that the GHRH response is maintained in 
elderly adults [159]. Similarly, the literature is divided as to whether altered feedback 
mechanisms may contribute to the decline in the GH/IGF-1 axis [160,161]. Although 
testosterone can influence the activity o f the axis, it is not thought to be the primary 
cause of the somatopause either [162]. Recently, studies have focused on the potential 
role o f ghrelin in the aetiology o f the somatopause. Experimental animal studies have 
suggested that the age-related decline in the GH/IGF-1 axis is not due to a reduction 
in the release or effects of ghrelin [163]. In contrast, human studies have suggested a 
decline in ghrelin secretion and function with age [164,165]. Plasma Ghrelin 
concentrations also positively correlate with serum IGF-1 concentrations in elderly 
human subjects [166]. Overall, it would seem that complex alterations in the 
stimulation, production and release of GHRH, Sn and ghrelin as well as altered 
sensitivity of the hypothalamus and pituitary to these hormones contribute to the 
development of the somatopause.
Whether the somatopause is a pathological or physiological adaptive response to 
ageing is a point of controversy. The observed increase in central adiposity and pro- 
atherogenic lipid profile with age is associated with increased risks of coronaiy 
atherosclerosis and hypertension [167]. Reduced IGF-1 levels in elderly individuals 
have been associated with increased risks of congestive cardiac failure and stroke 
[168,169]. Retrospective studies in hypopituitary patients have suggested increased 
risks of cardiovascular mortality and reduced life expectancy with AGHD [170,171], 
although this has not been shown in prospective studies [172]. It was hypothesized 
that increased life expectancy might be expected to occur with higher GH/IGF-1 
activity but this has not been proven. Patients with acromegaly have been shown to
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have increased cardiovascular risks and reduced life expectancy [173] and very old 
age is not associated with elevation of IGF-1 [174]. Experimental animal studies in 
species with congenital reductions in GH/IGF-1 axis activity appear to show increased 
life expectancy with reduced axis activity [175,176]. Anecdotal reports of human 
populations with untreated congenital GH deficiencies vary with regards to survival 
[177,178]. In addition, IGF-1 has been implicated as a risk factor in prostate, breast 
and colorectal cancers [179-181]. Thus, it has been postulated that the age related 
decline in the GH/IGF-1 axis may be an adaptive response to reduce cancer risk, 
improve insulin sensitivity and prolong longevity [182] but this would appear to be at 
the expense of increasing other intercurrent pathologies.
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2.4 - GH / IGF-1 and Collagen Metabolism
The effects of GH and IGF-1 on collagen metabolism and their implications on 
normal and pathological skin, cardiovascular, orthopaedic and respiratory 
physiology have been investigated. The effects o f axis activity and age have also 
been the subject o f investigation with regards to collagen production.
Early studies by Jorgensen et al using rat models looked non-specifically at the 
effects of growth hormone on granulation tissue and skin. They found GH increased 
granulation tissue collagen content and tissue strength but not in a dose dependent 
manner. They could not repeat the findings in a similar, later study [183,184]. In 
contrast, the same team found a dose dependent increase in both collagen content 
and strength of intact rat skin to GH administration [185]. Avian skin fibroblast 
models suggested GH and IGF-1 had a synergistic action on collagen production 
and could actually inhibit type I procollagen gene expression, with lGF-1 also 
stimulating collagenase activity [186],
Ghahary et al, investigating post-bum hypertrophic scar (Hsc) tissue, found 
increased expression of type I and type III procollagen mRNA in both normal and 
Hsc human skin fibroblasts exposed to IGF-1 [187]. The Hsc tissue was found to 
contain higher levels of IGF-1 compared to normal skin [187]. They also 
demonstrated Hsc fibroblasts had lower levels of collagenase mRNA and 
collagenase activity and that exposure to IGF-1 reduced these collagenase levels in 
both normal and Hsc fibroblasts [188]. The same team found that IGF-1 stimulated 
TGFp-1 expression (an important growth factor in fibroblast proliferation and 
function) in dermal fibroblasts and hypothesized that this may be one of the 
mechanisms by which IGF-1 mediated its effects [189]. IGF-1 has also been shown 
to stimulate IGFBP-3 release Ifom Hsc fibroblasts but in a heterogeneous manner, 
with the release dependant on the dermal layer the cell was originally derived from 
[190].
Keloid scars (Ksc) are characterized by abnormal fibroblast proliferation and 
overproduction of collagen [191]. Ksc fibroblasts are known to overexpress IGF-lr
41
[192]. Quercetin is a plant-derived compound that is a potent inhibitor of the 
enzymes involved in IGF-1 intra-cellular signalling pathways [191]. Phan et al 
found quercetin significantly reduced collagen type I and collagen type III 
expression by human Ksc fibroblasts [191]. Although the exact mechanism by 
which these changes were induced was not known, it was speculated that inhibition 
of IGF-1 induced MAP kinase activity, and subsequent phosphorylation of 
transcription factors such as Elk-1, was the most likely reason. Dahlgren et al, using 
a collagenase induced equine model of flexor tendonitis, demonstrated elevated 
hydroxyproline content of healing tendon treated with intra-lesional injection of 
IGF-1 associated with increased fibroblast proliferation [193]. However, there was 
no change in the proportion of collagens, unlike previous in-vitro studies [194], and 
it was noted that both control and IGF-1 tendons had virtually healed by the end of 
the study.
Bruel and Oxlund, investigating the effects of GH on the cardiovascular system 
using a rat model, found increased concentrations of collagen in the aorta, with a 
relative increase of type I collagen, in response to an 80 day course of GH [195]. 
Using a novel technique to assess in-vivo collagen deposition, they found GH 
increased collagen deposition in both the aorta and the left ventricle. The left 
ventricular deposition rate was noted to be five times greater than the aorta [196]. In 
contrast, the same group found in another study that although overall collagen 
content was increased, this was in proportion to the growth of the heart and GH 
actually reduced the concentration of collagen in the ventricles by seventeen percent 
[197]. There was no change in the relative amounts of type I or type III collagen 
either. These findings reflect the conflicting results in the literature [198,199]. 
Recently, IGF-1 has been shown to promote collagen synthesis by cardiac 
fibroblasts [200].
With age and senescence, the physical characteristics of the aorta change with 
increased stiffiiess and reduced elasticity. Bruel and Oxlund demonstrated reduced 
aortic collagen content with increasing age [201]. This has been confirmed by other 
studies revealing reduced aortic type I procollagen mRNA and collagen synthesis 
with age [202-203]. GH was found to increase the collagen content, concentration 
and relative ratio of type I to type III collagen in the aorta o f old rats as well as
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young rats but the magnitude of the response was diminished [204]. The authors of 
this paper suggested the observed decline in collagen turnover was related to the 
age related decline in the GH/IGF-1 axis. They noted, however, that the increased 
collagen observed with GH administration did not alter the physical properties of 
the aged aorta.
Other studies have also shown altered fibroblast function with age. Some ageing 
human fibroblasts have been shown to have elevated collagenase mRNA expression 
and activity with reduced procollagen type I mRNA and this was suggested to 
contribute to poor wound healing in the elderly [205]. Although the number of IGF- 
lr  expressed in young and aged human fibroblasts is the same, aged fibroblasts do 
not respond as vigorously to IGF-1 [206]. Elevated IGFBP-3 expression has also 
been observed in senescent fibroblasts and has been found to inhibit IGF-1 
mediated DNA synthesis [207].
GH administration to adults with GH deficiency states results in a variable rise in 
serum markers of type I and type III procollagen depending on the doseage 
administered [208]. This is associated with proportionately higher levels of type III 
procollagen propeptides. IGF-1 administration to adults with primary growth 
hormone resistance (Laron syndrome) also results in elevation of serum type 1 and 
type III procollagen propeptides [209,210]. In contrast to GH in GH deficiency, a 
proportionately greater rise in type I procollagen is observed but this is from a 
lower level in the untreated disease state. Although administration of both 
hormones resulted in apparent alterations of the procollagen ratios, this was 
observed in serum samples and reflected global connective tissue synthesis. Tissue- 
specific collagen ratios and the effect of GH/IGF-1 administration on them has not 
been investigated.
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2.5 - Conclusions
It is clear that the GH/IGF-1 axis continues an important role in adulthood beyond 
the pubertal growth spurt. It influences bodily fimctions including protein, 
carbohydrate, bone and fat metabolism. There is an age-related decline in the 
GH/IGF-1 axis that is one of the endocrinological hallmarks o f ageing. This can 
result in undesirable effects such as increased cardiovascular morbidity but also 
appears to be a protective response reducing oncogenic risk and promoting 
longevity. The GH/IGF-1 axis influences collagen metabolism and the effects are 
both time and tissue dependant. GH, IGF-1 and IGFBPs can all affect collagen 
production and collagenase activity. The ratios of type I:Type III collagens can be 
altered also. Age has been shown to alter fibroblast production of collagens, 
collagenases and fibroblast responsiveness to IGF-1 separate from the effects of the 
somatopause related GH/IGF-1 decline. Although alterations in collagen 
metabolism have already been observed in skin, tendon, aorta and heart tissue, it is 
likely that the GH/IGF-1 axis has a role in collagen metabolism at many other sites.
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Section Two:
A Prospective Case-Control Study of Growth Hormone Axis 
and Activity in Adult Inguinal Hernia Patients
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Chapter Three 
Methods
3.1 -  Introduction
Adult inguinal hernia development has been found to be a disease of collagen 
metabolism with altered ratios of collagens, altered MMP activity and recently 
TIMP activity being found to varying degrees in the skin, scar, fascia and hernial 
sacs of patients with primary, recurrent and incisional hernias. Altered fibroblast 
activity has also been observed. Due to the complex control mechanisms of the 
ECM environment, the reasons behind this altered metabolism have not been fully 
elucidated.
The GH/IGF-1 axis, and the somatopause, have been shown to influence collagen 
metabolism, collagen ratios and MMPs in skin, bone and vascular tissues. The peak 
decline in activity occurs in the fifth and sixth decades which coincides with the 
peak incidence of adult inguinal hernia development. It was therefore hypothesized 
that the GH/IGF-I axis, in particular the somatopause, may have a role in the 
aetiology of adult inguinal hernia development. As aforementioned in Section 1, the 
gonadal axis also declines with age and influences body habitus. It was 
hypothesized that this could be a ‘confounding’ aetiological factor and was 
therefore investigated also.
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3.2 -  Aims
1. To assess if men with inguinal hernia had reduced growth hormone (GH) / 
insulin-like growth factor-1 (IGF-1) axis activity (represented by lower IGF- 
1 concentrations) compared to age-matched controls without such a history.
2. To determine if reduced gonadal axis activity, as estimated by testosterone 
and free androgen index, was present in men with inguinal hernia compared 
to age-matched controls.
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3.3 -  Subjects
Adult male patients referred to the Southern General Hospital with an inguinal 
hernia were reviewed in a dedicated clinic. All hernia patients over 35 years old 
were considered for inclusion in the study. Exclusion criteria included current or 
past medical history o f endocrine pathology, aneurysmal vascular disease, diabetes, 
liver or renal pathology and malignancy to exclude factors known to influence GH / 
IGF-1 axis activity. All other medical histoiy, including smoking history, was 
noted. Height/weight measurements were taken for calculation of body mass index 
(BMI) by the formula [weight]/[height]^ (see appendices 6,1-6.3). A single venous 
blood sample was taken in the morning between 9am and 12pm from the 
antecubital fossa for evaluation of serum IGF-1 (as a surrogate marker of GH / IGF- 
1 axis activity). Testosterone and sex hormone binding globulin (SHBG) were also 
evaluated to allow calculation of the Free Androgen Index (as a marker of androgen 
activity). The subsequent operative findings were reviewed to delineate the 
proportion of direct and indirect hernias.
Healthy controls were sought from patients attending for minor and day case 
operative procedures and patients attending surgical and orthopaedic outpatient 
clinics for the follow-up of benign disease. Controls were age-matched within one 
year to the hernia patients and as close as possible for BMI. In addition to the above 
exclusion criteria, controls were not included if  a current or past history of any type 
o f ventral abdominal wall hernia was noted. Clinical examination was performed by 
two independent fully-qualified medical practitioners to exclude undiagnosed groin 
hernias.
Informed consent was obtained from all participants. The study was approved by 
the Southern General Hospital ethics committee.
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3.4 - Blood Sample Assays
Once taken, blood samples were placed in a centrifuge at SOOOrpm for lOminutes 
and frozen at -20”C for later batch analysis.
IGF-1
A 2-site immunoenzymometric (lEMA) assay was performed using the Nichols 
Advantage IGF-1 assay (Nichols Institute Diagnostics, California, USA). Pre­
treatment acid-ethanol extraction was performed to avoid interference from binding 
proteins. The detection limit was 10 ug/L. The inter-assay coefficient of variation 
using quality control pools at 80 & 260 ug/L was 7%.
Testosterone
A commercial competitive chemiluminescence immunoassay was performed using 
the Bayer Centaur analyser (Bayer Healthcare, Leverkusen, Germany). A pre­
treatment step with a testosterone releasing agent released bound testosterone fi'om 
endogenous binding proteins. The detection limit was 0.5 nmol/L. The inter-assay 
coefficient of variation using quality control pools at 3, 21 & 44 nmol/L was 9%.
SHBG
A 2-site chemiluminescent immunometric assay was performed using the DEC 
Immulite 2000 analyser (Diagnostic Products Corporation, California, USA). The 
detection limit was 1 nmol/L. The inter-assay coefficient of variation using quality 
control pools at 5, 38 & 80 nmol/L was 4%.
Free Androgen Index
This was calculated using the formula:
Free Androgen Index = [testosterone (nmol/1) / SHBG (nmol/1)] x 100
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3.5“ Statistical Analysis
Baseline characteristics were expressed as median (interquartile range) or 
proportions as appropriate. Serum hormone assays were expressed as mean +/- 
standard deviation. Differences between baseline characteristics were analyzed 
using chi-squared or Mann-Whitney U-tests where appropriate. Comparison of 
means between groups was performed using one-way analysis of variance 
(ANOVA). Simple linear correlation was performed using bivariate Pearson’s 
correlation and the F-test was used to assess significance.
P<0.05 was considered statistically significant.
Statistical analysis was performed using Statistical Package for the Social Sciences 
vlO.O for Windows (SPSS, Chicago, Illinois, USA).
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Chapter 4 
Results
4.1 Recruitment and baseline characteristics
47 hernia patients were recruited from 100 male patients referred to the southern 
general hospital with a diagnosis of inguinal hernia between 2003 and 2005. 47 
control patients were recruited according to the above criteria from 850 patients 
reviewed attending the southern general hospital daycase surgery, endoscopy, 
general surgical and orthopaedic outpatient departments over the period 2004 to 
2005. 3 hernia patient serum samples were not available for processing at the time 
of batch analysis. These patients and their corresponding age-matched controls were 
therefore excluded leaving 88 subjects for analysis.
Table 3 summarises the characteristics of these patients. There were no significant 
differences in age, height, weight, smoking history or presence of non-excluding 
co-morbidity between the two groups. There was a statistically significant 
difference in mean BMI (mean BMI hernia 25.1 vs control 26.6; p=0.035) but when 
the BMI was considered in terms of the recognized healthy (18.5-25), overweight 
(25.1-30) and obese (>30.1) ranges there was no difference between the hernia and 
control patients.
Table 4 summarises the clinical characteristics of the hernias identified. 57% (25) 
were right-sided with a median history of 4 months. Of the 44 patients recruited, 3 
patients subsequently declined surgery, 2 were known still to be on the waiting list 
and 7 cases were unavailable for review at the time o f batch analysis. This left 32 
patients with full operative details. 22.7% (10) were direct hernias (defined as 
occurring lateral to the deep inferior epigastric artery), 31.8% (14) were indirect 
hernias (defined as occurring medial to the deep inferior epigastric vessels),
13.6% (6) had combined defects, 2.3% (1) involved recurrent hernias and 2.3% (1) 
were not defined.
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H ernia Control /ï-value
Age (yr) 57.0 (48.2-65.0) 
[57.7 +/-11.7]
57.5(48.5-65.7)
[58.11+/-11.7]
n.s.
Height (cm) 173.8(168.2-177.9) 
[173.0+/-7.0]
172.4(167.1-177)
[172.0+/-7.0]
n.s
Weight (kg) 76.9(68.9-84.2) 
[77.1 +/-10.9]
80.5(70.2-87.3) 
[80.5+/-11.9]
n.s
BMI 25.1(23.5-27.7) 
[25.7 +/-2.8]
26.6(24.9-30.0) 
[27.3 +/-3.7]
/;=0.035
History of Smoking 54.5% (24) 54.5% (24) n.s
Presence of Co-morbidity 20.5% (9) 25% (11) n.s.
Table 3. Characteristics of Patients. (n=44 per group)
Continuous data expressed as median with interquartile range with mean and standard deviation in 
brackets beneath. Categorical data expressed as percentage with absolute value in brackets. n.s,=non- 
significant
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Hernia Characteristics
Side Right 57% (25)
Left 40.7% (18)
Bilateral 2.3% (1)
Duration Mean 12.8mths(l-120mths) Median 4mths(2-12mths)
Operative Type Direct 22.7% (10)
Indirect 31.8% (14)
Combined 13.6% (6)
Reeurrent 2.3% (1)
Not Defined 2.3% (1)
Not Known 27.3% (12)
Table 4. Clinical Characteristics of Hernias.
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4.2 IGF-1 Assay Results
Comparison of IGF-1 assays with age in hernia and control groups 
Both hernia and control groups displayed a negative correlation between age and 
serum IGF-1 concentrations with pearson’s correlation coefficients of -0.176 and 
-0.166 respectively. These were not statistically significant (See Fig.4 and Table 5). 
Controlling for BMI did not alter these findings but controlling for FAI weakened the 
correlation findings in both groups.
Comparison of IGF-1 assays between groups
Figure 5 presents simple boxplots displaying the IGF-1 concentrations o f both cohorts 
of patients. The hernia group’s mean IGF-1 concentration was lower at 
125.7|Lunol/L+/-47.7 compared with 135.0pmol/L+/-50.9 of the control group but this 
did not reach statistical significance (p=0.374, see Table 6). Subgroup analysis of the 
direct and indirect hernia cohorts did not reveal a significant difference either.
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Figure 4a / 4b. Correlation between IGF-1 and Age in hernia and control groups.
Pears Coeff = Pearson’s Correlation Coefficient
55
Correlation Pearson’s Co efficient p-value
AU subjects IGF-1-Age -0.168 0.118
Hernia IGF-1-Age -0.176 0.254
Control IGF-l-Age -0.166 0.282
* = statistica ly significant
Table 5. Pearson’s correlation co efficients for IGF-1 vs age.
56
200 -
50 —
G roup
Figure 5. Comparisou of serum IGF-1 levels between hernia and control groups.
Hernia Control
All Cases 125.7+/-47.7 (111.1-140.1) 135.0+7-50.9(19.6-150.5)
F=0.80 p=0.374
Direct sub-group 117.2+7-36.3 (15.2-139.1) 131.5+7-45.2(104.1-158.8)
F=0.80 p=0.383
Indirect sub-group 135.8+7-58.0 (91.3-180.3) 143.2+7-61.6 (95.9-190.6)
F=0.70 p=0.795
* =  statistically significant
Table 6. Comparison of IGF-1 assays between hernia and control groups.
Values expressed as mean with standard deviation and 95% confidence intervals in brackets. Statistical 
analysis by ANOVA.
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4.3 Testosterone Assay and Free Androgen Index Results
Comparison of Testosterone assays with age in hernia and control groups
The hernia group displayed a negative correlation between age and serum testosterone
concentrations with a pearson’s correlation coefficient of -0.175.
There was no correlation between serum testosterone and age in the control groups 
(see Fig.6 and Table 7). Controlling for BMI weakened the hernia group correlation 
findings.
Comparison of Free Androgen Index with age in hernia and control groups 
Both hernia and control groups displayed a statistically significant negative 
correlation between age and calculated FAI (see Fig.7 and Table 7).
The hernia group pearson’s correlation was -0.366 (p=0.015), the control group 
pearson’s correlation was -0.313 (p=0.038).
Controlling for BMI strengthened these findings with a p-value of 0.002 and 
significance was also maintained when controlling for IGF-1 (hernia p= 0.032, control 
p= 0.070).
Comparison of Testosterone assavs between groups
Figure 8 presents simple boxplots displaying the testosterone concentrations of both 
cohorts. The hernia group had a higher mean testosterone concentration of 
19.4nmol/L+/-6.4 compared with 14.8nmol/L+/-6.6 of the control group. This was 
statistically significant (p=0.001, see Table 8). This significant difference was also 
reflected in subgroup analysis of direct and indirect hernias (direct p=0.004, 
indirect p=0.034).
Comparison of Free Androgen Index between groups
Figure 9 presents simple boxplots displaying the calculated FAIs of both cohorts. The 
hernia group had a higher mean FAI of 50.8+/-15.9 compared with 43.1+/-19.4 of the 
control group. This was statistically significant (p=0.044, see Table 9). This result was 
not reflected in subgroup analysis.
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Figure 6a / 6b. Correlation between Testosterone and Age in hernia and control
groups.
Pears Coeff = Pearson’s Correlation Coefficient
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Figure 7a / 7b. Correlation between FAI and Age in hernia and control groups.
Pears Coeff = Pearson’s Correlation Coefficient
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Correlations Pearson’s Co efficient p-value
All subjects T estosterone-Age -.040 0.709
FAI-Age -0.331 0.002*
H ernia T estosterone-Age -0.175 0.256
FAI-Age -0.366 0,015*
Control Testosterone-Age -0.097 0.531
FAI-Age -0.313 0.038*
* = statistica ly significant
Table 7. Pearson’s correlation co-efficients for Testosterone and FAI vs Age.
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Figure 8. Comparison of serum Testosterone levels between hernia and control 
groups.
Hernia Control
Whole Group 19.4+/-6.4 (17.5-21.3) 14.8+/-6.6 (12.8-16.8)
F=11.2 p=0.001*
Direct sub-group 18.9+/-6.1 (15.2-22.6) 11.7+/-5.4 (8.4-15.0)
F=9.98 p=0.004*
Indirect sub-group 20.0+/-4.9 (16.2-23.8) 15.0+/-4.27 (11.7-18.3)
F=5.37 p=0.034*
*  = statistically significant
Table 8. Comparison of Testosterone assays between hernia and control groups.
Values expressed as mean with standard deviation and 95% confidence intervals in brackets. Statistical 
analysis by ANOVA.
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Figure 9. Comparison of FAI calculations between hernia and control groups.
Hernia Control
Whole Group 50.8+/-15.9 (46.0-55.7) 43.1+/-19.4 (37.2-49.0)
F=4.17 p=0.044*
Direct sub-group 45.0+/-9.4 (39.3-50.7) 44.0+/-15.6 (35.1-54.0)
F=0.01 p=0.928
Indirect sub-group 50.7+/-17.6 (37.7-64.2) 46.9+/-21.1 (30.6-63.1)
F=0.17 p=0.686
* = statistically significant
Table 9. Comparison of FAI calculations between hernia and control groups.
Values expressed as mean with standard deviation and 95% confidence intervals in brackets. Statistical
analysis by ANOVA.
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Chapter 5
5.1 Discussion
The main aim of this study was to assess if there was an association between reduced 
growth hormone axis activity and inguinal herniation. Section 1 of this thesis clearly 
demonstrated the potential influence of the GH/lGF-1 axis on collagen metabolism 
and the importance of altered collagen metabolism in the aetiology o f inguinal 
herniation. To the author’s knowledge, the hypothesis that the two may be linked has 
never been suggested or investigated before. This research was therefore novel and 
original.
Serum IGF-1 assays within this cohort negatively correlated with age in keeping with 
the established age-related decline in axis activity seen in the literature [134-137]. 
Although the median IGF-1 concentration was lower in the hernia group, and the 
negative correlation appeared to be greater, this did not reach statistical significance. 
There are reasons that a significant association was not found. It is possible that 
patients with occult endocrine or renal disease could have influenced these findings. 
Also, clinical examination may not have fully excluded occult hernias in controls. 
Even though this cohort was carefully selected, a degree of biological variability in 
serum hormone activity was observed in both groups that could have affected 
analysis. It is clear that, although there is a recognized age-related decline in GH / 
IGF-1 axis activity and the axis can influence collagen metabolism, this activity and 
influence at the tissue level can differ from site to site and does not necessarily always 
reflect ‘global’ axis activity. It is possible, therefore, that the reduced IGF-1 
concentrations and effects may be more evident within the tissues o f the inguinal 
canal. This is an area that would benefit from further assessment.
Serum testosterone and free androgen index within this cohort also negatively 
correlated with age in keeping with the literature [135.137]. The findings of 
significantly elevated testosterone and free androgen index levels in the hernia 
patients compared to the control patients was unexpected. Age-related decline in the 
male gonadal axis is a well documented, but not universal, phenomenon in adult
64
males [135,137]. Similar to the GH/IGF-1 axis, this decline has been associated with 
changes in body habitus including reduced lean body mass and reduced bone mineral 
density. The evidence for this is, however, inconsistent within the literature 
[135,137,148,149]. Whether these effects are independent of, or additive to, the 
GH/IGF-1 axis is also not clear [148,149,212]. Figure 6b initially appeared to suggest 
that the control group were not behaving as expected of a normal population, with no 
correlation between age and testosterone levels. The FAI, however, did correlate and 
is a much more sensitive indicator o f gonadal axis activity. Appendix 6.6 displays the 
origins of the control patients. They all were attending hospital with benign conditions 
that were not known to influence the gonadal axis. In addition, none of the controls 
had a history o f current or previous ventral abdominal wall or groin hernias either as 
adults or children. It is likely, therefore, that Figure 6b represents a random sampling 
effect.
Much of the research in the influence of the gonadal axis on collagen metabolism is in 
the field of bone metabolism. Although conflicting, results here have shown either no 
influence or a positive influence o f testosterone on collagen metabolism [213-216]. In 
vascular research, testosterone has been found to be a positive regulator o f lysyl 
oxidase activity [217] and can influence MMP activity. One study, by Natoli et al 
using an experimental human model of aortic smooth muscle, found that testosterone 
reduced extra-cellular matrix collagen deposition (types I, II and III) by 30%. They 
also found testosterone positively regulated MMP-3 gene expression [218].
There is therefore evidence within the current literature that the male gonadal axis can 
regulate the extracellular matrix. The exact role, however, at different sites is 
controversial. The male gonadal axis assays in this study were performed to take into 
account reduced testosterone levels as a confounding factor when considering the 
GH/lGF-1 axis in inguinal hernia development. The elevated levels found in the 
hernia patients were still within normal limits and certainly excluded reduced axis 
activity as an aetiological factor.
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The ideal method to have investigated whether an aetiological relationship existed 
between age-related hormonal changes and inguinal hernia development would have 
been to perform a large scale epidemiological study with a longitudinal nested case- 
control study. The cost o f analysis (see appendix 6.4) would have been prohibitively 
expensive and the study logistically challenging. The case-control design chosen 
represented a realistic and pragmatic approach that was both affordable and 
achievable in the given time. The tight exclusion criteria selected, although 
challenging to employ in the West of Scotland population, were aimed at reducing the 
impact of confounding variables on this smaller sample size. Initially, only direct 
herniation was to be assessed but further review of the literature indicated that 
classification of inguinal hernias was less relevant to the aetiology o f adult inguinal 
herniation (see chapter 1.6). This opened the study to all adult males presenting with 
inguinal herniation.
The gold standard for assessing GH axis activity is an insulin tolerance test [211], The 
potential risks of this procedure made it inappropriate to be used in this setting. Serum 
IGF-1 assays were used as they have been shown to correlate well with axis activity 
and are not subject to the same diurnal variation as growth hormone [211]. Serum 
IGF-1 binding proteins were not measured as these have not been shown to correlate 
as well with axis activity [211], were expensive to assay and did not offer any 
advantage in addition to serum IGF-1.
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5.2 Conclusions
The aetiology of adult inguinal hernia development is multi-factorial. Although 
genetic, anatomical and physiological factors are involved disordered extra-cellular 
matrix and collagen metabolism is a key feature. Reduced ratios of type I : type III 
collagen have been noted related to increased expression of type III collagen and 
possibly to altered MMP mediated collagen degradation. The GH/IGF-1 axis also 
influences collagen and the extra-cellular matrix in a heterogeneous fashion 
dependant on time and location.
This study did not reveal a significant association between reduced somatotrophin 
axis activity and adult male inguinal hernias. Male gonadal axis activity was elevated 
in this group (the significanee of which was unclear) but there was no association 
between reduced gonadal axis activity and hernia development either. Overall, the 
results suggest that the recognized hormonal changes associated with adult male 
ageing are not aetiological factors in adult male inguinal hernia development. Further 
research in this area is warranted to confirm these findings.
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Chapter 6 
Appendices
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Appendix 6.1 -  Hernia Data Collection Form 
G.H. in Inguinal Hernia Study
PATIENT DETAILS
Hospital Number: 
Surname:
Forename:
Date of Birth: / /
Inclusion Criteria (all answers should be yes)
>35yrs YES / NO
Inguinal Hernia YES / NO
Consent YES / NO
Bloods taken IGF-1 YES / NO
GH YES/ NO
TESTOSTERONE YES / NO
FREE ANDROGEN BINDING INDEX YES / NO
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DETAILS OF HERNIA
Is hernia Primary? yes / no
Recurrent? yes / no
Duration of Hernia  mths
Side of Hernia left / right / bilat.
Clinical Type of Hernia Direct /  Indirect / Combined / Recurrent
Operative Findings Direct / Indirect / Combined / Recurrent
PATIENT DEMOGRAPHICS
Height: cm Weight: Kg
Smoker: Yes / No
If yes,
Duration yr mth
Amount cigs / wk
Vascular Disease: Yes / No
If yes,
PVD / Aneurysm / IHD / Other (specify)
Endocrine Disease: Yes / No 
If yes,
Specify
Diabetes: Yes / No
All other PMH:
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Appendix 6.2 -  Control Data Collection Form
G.H. in Inguinal Hernia Study
CONTROL FOR HERNIA PATIENT No. 
PATIENT DETAILS
Hospital Number:
Surname:
Forename:
Date of Birth: / /
Inclusion Criteria (all answers should be yes)
Matched for Age, BMI & Co-morbidity YES / NO
Ciinical Absence of Inguinal Hernia YES / NO
(2 clinicians in accordance)
Clinician 1 Date
Clinician 2 Date
Consent YES / NO
Bloods taken IGF-1 YES / NO
GH YES/NO
TESTOSTERONE YES / NO
FREE ANDROGEN BINDING INDEX YES / NO
71
PATIENT DEMOGRAPHICS
Height: cm Weight: Kg
Smoker: Yes / No
If yes,
Duration yr mth 
Amount cigs / wk
Vascular Disease: Yes / No
If yes,
PVD / Aneurysm / IHD / Other (specify)
Endocrine Disease: Yes /  No 
If yes.
Specify
Diabetes: Y es/N o
All other PMH:
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Appendix 6.3 -  Patient Information and Consent Forms
Is growth hormone associated with the development of 
inguinal hernia?
Inguinal hernia are a common surgical problem requiring treatment. Understanding 
why they develop is very important in order to help us treat them effectively. Many 
different factors have been implicated including inherited factors, differences in our 
tissue and muscle production and the strength o f those muscles. Growth hormone is a 
natural body hormone that helps control the production and make up of our body 
tissues. It is possible that naturally lower levels of this hormone may contribute to the 
development of inguinal hernia. We are currently investigating whether this is true by 
comparing growth hormone levels in patients with and without inguinal hernia to see 
if there is a connection.
You have been identified as a patient who could assist in this study. This would 
involve taking one sample o f blood for analysis and collecting some information from 
your medical case notes. All information would be anonymous and you would not be 
identified personally.
There is a consent form to sign if you are interested in assisting in this study. You do 
not need to take part and your care will not be affected at all if you choose not to 
participate.
You can contact Mr Paul Witherspoon at the Southern General Hospital if you have 
any queries on 0141-201-1100.
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SOUTHERN GENERAL HOSPITAL 
CONSENT FORM -  Growth Hormone Study
PATIENT NAME  ........................................ DATE OF BERTH.
To be completed by the Patient
. Have you read the Patient Information?
. Have you had an opportunity to ask questions and discuss this study? 
. Have you received satisfactory answers to all your questions?
. Have you received enough information about the study?
Who have you spoken to?
Dr/Mr/Ms
Please Tick
Yes No□ □
□ □
□ □
□ □
Do you understand that you are free to withdraw from the study - 
at any time
without having to give a reason
and without affecting your future medical care?
Do you agree to take part in this study?
□□□□
□□□□
Do you have any reason to believe you are or may be pregnant?
YES, I may be pregnant 
NO, I am not pregnant
□□
Signed.............................
Name in Block Letters. 
Signature o f  Witness.... 
Name in Block Letters.
Date.
Date.
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Appendix 6.4 -  Cost Analysis
Analysis
lGF-1 - £7.89 per sample
Testosterone-£11 per sample
Sex Hn Binding Globulin - £5 per sample
Technician Support / Lab costs
£22 per sample
Total cost per patient - £45.89 
Grand Total for 94 subjects = £4,313.66
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Appendix 6.5 -  Case Summaries
Age Height Weight BMI Smoker Comorb IGFl Testosterone SHBG FAl
Hernia 1 78 170.1 87.2 30.2 ex No 99.00 13.50 55.00 25.00
Control 79 174.0 94.0 31.0 smoker Yes 175.00 6.00 30.00 20.00
2 62 171.5 64.8 22.0 no Yes 75.00 20.40 48.00 43.00
Control 62 179.0 70.0 21.9 no No 184.00 21.90 83.00 26.00
3 74 158.5 67.4 26.8 no Yes 75.00 24.80 40.00 62.00
Control 75 167.0 87.5 31.4 ex Yes 171.00 16.80 58.00 29.00
4 77 171.0 68.8 23.5 smoker No 96.00 26.70 47.00 57.00
Control 77 164.0 64.9 24.1 ex No 111.00 18.40 69.00 27.00
5 49 177.5 85.3 27.1 no Yes 123.00 20.30 33.00 62.00
Control 47 174.0 87.0 28.7 ex No 249.00 10.00 39.00 26.00
6 50 174.9 87.0 28.4 smoker No 211.00 15.50 21.00 74.00
Control 50 170.5 97.5 33.5 no No 90.00 10.80 32.00 34.00
7 78 156.8 57.7 23.5 smoker No 127.00 15.80 42.00 38.00
Control 76 172.7 66.0 22.1 no Yes 67.00 18.60 55.00 34.00
8 81 163.0 70.0 26.3 ex No 57.00 6.70 28.00 24.00
Control 81 165.1 57.3 21.0 smoker Yes 158.00 19.70 48.00 41.00
9 58 173.0 69.2 23.1 smoker Yes 149.00 18.50 43.00 43.00
Control 59 167.0 83.5 29.9 no No 119.00 5.00 22.00 23.00
10 67 184.0 81.0 23.9 no No 78.00 19.00 37.00 51.00
Control 69 182.0 105.0 31.7 smoker No 146.00 7.50 21.00 36.00
11 41 175.3 74.0 24.1 smoker Yes 245.00 24.50 36.00 68.00
Control 40 176.0 82.4 26.6 no No 257.00 22.40 41.00 55.00
12 64 160.0 71.7 28.0 smoker No 76.00 10.30 23.00 45.00
Control 64 156.0 68.0 27.9 no No 95.00 15.30 40.00 38.00
13 55 179.0 84.0 26.2 smoker No 183.00 22.20 48.00 46.00
Control 55 175.3 90.0 29.3 smoker Yes 113.00 13.90 25.00 56.00
14 39 174.0 80.0 26.4 no No 122.00 35.80 40.00 90.00
Control 36 163.0 73.0 27.5 no No 77.00 11.70 27.00 43.00
15 60 163.0 58.2 21.9 no No 185.00 26.30 49.00 54.00
Control 60 172.0 92.0 31.1 smoker Yes 118.00 7.50 15.00 50.00
16 45 174.5 89.0 29.2 smoker No 65.00 12.40 22.00 56.00
Control 46 173.5 76.0 25.4 no No 80.00 7.50 31.00 24.00
17 48 180.5 80.0 24.6 smoker No 97.00 9.40 27.00 35.00
Conti'ol 48 180.0 80.0 24.7 no No 69.00 9.10 29.00 31.00
18 54 175.0 107.8 35.2 no No 83.00 27.40 60.00 46.00
Control 54 172.0 115.0 38.9 no Yes 241.00 9.20 14.00 66.00
19 65 170.0 71.6 24.8 ex Yes 69.00 13.60 42.00 32.00
Control 65 182.0 86.0 26.0 smoker No 114.00 18.00 64.00 28.00
20 71 168.0 60.6 21.5 no No 145.00 20.80 35.00 59.00
Control 70 170.0 64.0 22.1 ex No 149.00 33.40 86.00 39.00
21 35 166.0 64.3 23.3 no No 84.00 19.00 47.00 40.00
Control 35 182.0 96.2 29.0 ex No 152.00 11.80 24.00 49.00
22 56 182.5 82.2 24.7 no No 162.00 19.40 83.00 23.00
Control 56 177.0 78.0 24.9 no Yes 121.00 8.70 27.00 32.00
23 41 176.0 68.4 22.1 smoker No 77.00 27.30 58.00 47.00
Control 51 173.0 74.4 24.9 ex No 135.00 31.80 61.00 52.00
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Age Height Weight BMI Smoker Comorb IGFl Testosterone SHBG FAI
24 52 165.1 64.8 23.8 no No 243.00 22.60 45.00 50.00
Control 52 170.0 75.0 26.0 no Yes 106.00 10.90 41,00 27.00
25 70 171.0 81.2 27.8 smoker No 148.00 24.90 45.00 55.00
Control 71 165.0 70.0 25.7 no No 104.00 16.70 34.00 49.00
26 69 168.0 70.4 24.9 smoker No 165.00 26.40 43.00 61.00
Control 69 167.5 71.0 25.5 smoker No 174.00 14.60 29.00 50.00
27 54 167.0 72.0 25.8 smoker Yes 82.00 14.50 55.00 26.00
Control 55 157.5 66.0 26.6 no No 141.00 23.60 36.00 66.00
28 62 167.0 64.0 22.9 no No 62.00 13.20 33.00 40.00
Control 62 171.0 88.0 30.1 no No 134.00 14.70 29.00 51.00
29 61 176.0 89.0 28.7 smoker No 98.00 16.50 41.00 40.00
Control 61 174.5 74.5 24.5 no No 101.00 12.90 39.00 33.00
30 41 184.0 99.0 29.2 ex Yes 104.00 14.50 24.00 60.00
Control 41 182.9 88.9 26.6 no No 232.00 23.30 37.00 63.00
31 52 171.4 73.7 25.1 no No 183.00 24.50 26.00 94.00
Control 52 161.5 67.0 25.7 no No 138.00 20.10 48.00 42.00
32 46 183.0 74.8 22.3 no No 146.00 26.70 37.00 72.00
Control 46 173.5 77.0 25.7 smoker No 116.00 13.50 11.00 123.00
33 54 169.0 82.8 29.0 no No 117.00 25.20 56.00 45.00
Control 55 167.5 85.0 30.3 smoker No 143.00 15.40 25.00 62.00
34 48 176.0 82.5 26.6 no Yes 184.00 20.00 25.00 80.00
Control 48 169.0 86.0 30.1 smoker No 215.00 11.60 14.00 83.00
35 58 169.0 66.0 23.1 smoker No 145.00 20.70 48.00 43.00
Control 58 172.0 73.0 24.7 smoker No 161.00 17.40 38.00 46.00
36 60 174.0 74.4 24.6 ex No 161.00 9.40 20.00 47.00
Control 61 157.0 85.0 34.5 smoker Yes 142.00 4.60 17.00 27.00
37 62 171.0 87.4 29.9 smoker No 149.00 18.90 41.00 46.00
Control 63 167.0 87.0 31.2 smoker Yes 21.00 22.10 81.00 27.00
38 65 183.0 84.2 25.1 no No 145.00 22.60 48.00 47.00
Control 65 181.0 96.0 29.3 smoker No 120.00 14.30 39.00 37.00
39 56 179.0 93.0 29.0 smoker No 142.00 8.20 18.00 46.00
Control 57 179.5 80.0 25.0 no No 111.00 15.30 50.00 31.00
40 43 176.0 81.4 26.3 no No 127.00 10.90 26.00 42.00
Control 43 175.0 70.0 22.9 ex No 102.00 4.10 16.00 26.00
41 65 173.6 79.0 26.2 smoker No 136.00 16.20 30.00 54.00
Control 66 171.0 81.0 27.7 ex No 175.00 12.40 17.00 73.00
42 73 184.0 83.0 24.5 no No 120.00 21.60 46.00 47.00
Control 74 181.0 69.0 21.1 no No 58.00 11.90 49.00 24.00
43 46 178.0 71.4 22.5 no No 63.00 27.70 41.00 68.00
Control 46 180.0 86.0 26.0 smoker No 149.00 21.40 48.00 45.00
44 55 181.0 90.0 27.5 ex No 126.00 18.40 34.00 54.00
Control 57 177.0 84.0 27.0 ex No 108.00 14.30 27.00 53.00
45 36 185.4 80.0 23.3 smoker No
Control 36 180.0 84.5 26.0 smoker No 133.00 31.80 50.00 64.00
46 83 170.1 86.0 29.7 smoker Yes
Control 82 177.8 87.0 27.5 smoker Yes 201.00 12.80 50.00 26.00
47 56 172.7 80.0 26.8 no No
Control 56 165.0 89.0 32.7 smoker Yes 137.00 16.10 43.00 37.00
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Appendix 6.6 “ Control Patient Demographics
Source Number Recruited Presenting Condition(s)
Orthopaedic Clinic 33 Osteoarthritis
General Surgery 8 Benign ano-rectal (5) 
Benign skin lesions (3)
Endoscopy Suite 3 Dyspepsia
Day Surgery 3 EU A Rectum (1) 
Varicose Veins (1) 
Arthroscopy (1)
There were no noted histories of current, previous or childhood hernias.
There were no noted histories o f liver, renal, endocrine, diabetic, aneurysmal or 
malignant pathology.
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